Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, dal 1982 In collaborazione con l'Associazione Culturale Pediatri

Caso contributivo

PDF MeBrain

Due casi di encefalite da varicella zoster virus

Two cases of Varicella Zoster virus encephalitis

Antonio Marchesini, Lorenzo Tartagni, Domenica Rizzi, Giacomo Brusa
UOC Pediatria e Neonatologia, Ospedale “San Salvatore di Pesaro”, AST Pesaro Urbino

Ottobre 2025 | DOI: 10.53126/MEBXXVIIIO200

Abstract
The paper reports two cases of varicella zoster virus (VZV) encephalitis in 11-year-old girls, one previously vaccinated and the other with a history of varicella. Both presented with headache, neck stiffness, vomiting, and vesicular rash; fever was absent in one case. Blood tests and brain CT were normal, while cerebrospinal fluid revealed hypoglycorrhachia, elevated protein and mononuclear pleocytosis. After initial empirical therapy with cefotaxime and acyclovir, the latter was continued alone for 14 days, with progressive clinical improvement. Brain MRI and immunological tests were normal; EEG abnormalities resolved at follow-up. Although uncommon, VZV is a relevant cause of meningoencephalitis in immunocompetent children, generally with a favourable prognosis. Rash may be absent in more than one-third of cases, and even the vaccine strain can reactivate, thus VZV must be considered in the differential diagnosis regardless of vaccination history or cutaneous findings.
Riassunto
Riportiamo due casi di encefalite da virus varicella-zoster (VZV) in bambine di 11 anni, una vaccinata e l’altra con pregressa varicella. Entrambe presentavano cefalea, rigidità nucale, vomito ed esantema vescicolare; la febbre era assente in un caso. Gli esami ematici e la TC encefalo risultavano normali, mentre il liquor mostrava ipoglicorrachia, iperproteinorrachia e pleiocitosi mononucleata. Dopo terapia empirica con cefotaxime e aciclovir, quest’ultimo è stato proseguito in monoterapia per 14 giorni, con progressivo miglioramento clinico. RM encefalo ed esami immunologici erano nella norma; l’EEG, inizialmente alterato, si è normalizzato al follow-up. Sebbene raro, il VZV rappresenta una causa rilevante di meningoencefalite in bambini immunocompetenti, con prognosi generalmente favorevole. L’eruzione cutanea può mancare in oltre un terzo dei casi e anche il ceppo vaccinale può riattivarsi, rendendo necessaria l’inclusione del VZV nella diagnosi differenziale indipendentemente da anamnesi vaccinale o quadro cutaneo.
Contenuto riservato

Per leggere l'articolo è necessario effettuare il login.

Per l'acquisto del singolo articolo scrivi a abbonamenti@medicoebambino.com (la mail si prepara da sola con gli estremi dell'articolo); se accedi, la richiesta parte con un click.

Bibliografia

  1. Kennedy PG. Varicella-zoster virus latency in human ganglia. Rev Med Virol 2002;12(5):327-34. DOI: 10.1002/rmv.362.
  2. Toczylowski K, Bojkiewicz E, Barszcz M, Wozinska-Klepadlo M, Potocka P, Sulik A. Etiology, Clinical Presentation and Incidence of Infectious Meningitis and Encephalitis in Polish Children. J Clin Med 2020;9(8):2324. DOI: 10.3390/jcm9082324.
  3. Moghadam AG, Yousefi E, Ghatie MA, Moghadam AG, Pouladfar GR, Jamalidoust M. Investigating the etiologic agents of aseptic meningitis outbreak in Iranian children. J Family Med Prim Care 2020;9(3):1573-77. DOI: 10.4103/jfmpc.jfmpc_1003_19.
  4. Lewandowski D, Toczylowski K, Kowalska M, et al. Varicella-Zoster Disease of the Central Nervous System in Immunocompetent Children: Case Series and a Scoping Review. Vaccines (Basel) 2024;12(9):1086. DOI: 10.3390/vaccines12091086.
  5. Grote V, von Kries R, Rosenfeld E, Belohradsky BH, Liese J. Immunocompetent children account for the majority of complications in childhood herpes zoster. J Infect Dis 2007;196(10):1455-8. DOI: 10.1086/522631.
  6. Kang DH, Kwak BO, Park AY, Kim HW. Clinical Manifestations of Herpes Zoster Associated with Complications in Children. Children (Basel) 2021;8(10):845. DOI: 10.3390/children8100845.
  7. Herlin LK, Hansen KS, Bodilsen J, et al. Varicella Zoster Virus Encephalitis in Denmark From 2015 to 2019-A Nationwide Prospective Cohort Study. Clin Infect Dis 2021;72(7):1192-9. DOI: 10.1093/cid/ciaa185.
  8. Tunkel AR, Glaser CA, Bloch KC, eet al; Infectious Diseases Society of America. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008;47(3):303-27. DOI: 10.1086/589747.
  9. Bookstaver PB, Mohorn PL, Shah A, et al. Management of Viral Central Nervous System Infections: A Primer for Clinicians. J Cent Nerv Syst Dis 2017;9:1179573517703342. DOI: 10.1177/1179573517703342.
  10. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000;342(9):635-45. DOI: 10.1056/NEJM200003023420906. Erratum in: N Engl J Med 2000;342(14):1063.
  11. American Academy of Pediatrics Committee on Infectious Diseases. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule. Pediatrics 2007;120(1):221-31. DOI: 10.1542/peds.2007-1089.
  12. Weinmann S, Chun C, Schmid DS, et al. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009. J Infect Dis. 2013;208(11):1859-68. DOI: 10.1093/infdis/jit405.
  13. Varela FH, Pinto LA, Scotta MC. Global impact of varicella vaccination programs. Hum Vaccin Immunother. 2019;15(3):645-57. DOI: 10.1080/21645515.2018.1546525.
  14. Galea SA, Sweet A, Beninger P, et al. The safety profile of varicella vaccine: a 10-year review. J Infect Dis 2008;197 Suppl 2:S165-9. DOI: 10.1086/522125.
  15. Grahn A, Studahl M. Varicella-zoster virus infections of the central nervous system – Prognosis, diagnostics and treatment. J Infect 2015;71(3):281-93. DOI: 10.1016/j.jinf.2015.06.004.
  16. Woodward M, Marko A, Galea S, Eagel B, Straus W. Varicella Virus Vaccine Live: A 22-Year Review of Postmarketing Safety Data. Open Forum Infect Dis 2019;6(8):ofz295. DOI: 10.1093/ofid/ofz295.